Skip to playerSkip to main content
  • 10 months ago
Donald Trump Hits India With 25% Tariff Plus Penalty For Doing Business With Russia | Tariff News
US President Donald Trump announced a 25% trade tariff on India, set to begin on the 1st of August. The announcement comes after prolonged negotiations between the two countries. In a statement, Trump said, "India will therefore be paying a tariff of 25%." He cited India's high tariffs, non-monetary trade barriers, and its significant military and energy purchases from Russia as reasons for the penalty. The development is seen as a disappointment for India, which had hoped for a different outcome, especially following the recent signing of an FTA with the UK. There is concern that the tariff could negatively impact the APAC market. While India's overall export basket to the US, excluding pharmaceuticals, is not extensive, any future tariffs on the pharmaceutical sector could create a major trade deficit for India.

Category

🗞
News
Transcript
00:00All right, big story that we're breaking at this hour, a big announcement that has been come,
00:09that is coming from President Donald Trump on 25% rate tariff on India.
00:15Finally, that announcement has been made.
00:17Donald Trump has spoken about it and I quote him,
00:19remember while India is our friend, we have over the years done relatively little business with them
00:25because their tariffs are far too high, among the highest in the world
00:29and they have the most strenuous and obnoxious non-monetary trade barriers of any country.
00:35Also, they've always bought a vast majority of their military equipment from Russia
00:39and Russia's largest buyer of energy, along with China.
00:43At a time when everyone wants Russia to stop the killing in Ukraine, all things not good.
00:49India will therefore be paying a tariff of 25%.
00:52That's the penalty for the above starting on the 1st of August.
00:56Thank you for your attention to this matter.
00:59Make America great again.
01:01That's what Donald Trump has said.
01:03Doing what was expected, however, extremely disappointing for India.
01:0825% tariff in India, something that India had been working very hard to negotiate for days and weeks, months together actually.
01:16But the trade deal has now been, in fact, it's been signed along dotted lines with this announcement.
01:21Coming in a 25% tariff, also taking a jibe at India for doing business with Russia.
01:27I'll be going across to my colleagues from India Today Global in a moment from now.
01:32But for the moment, first to Karishma Asudhani, my colleague from Business Today for the very latest on that.
01:37Karishma, disappointing but expected, isn't it?
01:40Absolutely disappointing.
01:42Absolutely disappointing.
01:44In fact, this is not something that you're expecting, especially after the UK FDA that was recently signed,
01:50where India's Commerce Minister has been reiterating that a fine example was set,
01:57a foundational example was set for the U.S. to negotiate with India.
02:02But it looks like India's substance of not compromising on its sensitive sectors of agri, dairy and genetically modified crops
02:14has led this 25% tariff on India.
02:18This is not going to go a long way.
02:20In fact, I was speaking to an economist today and he predicted that this sentiment was going to pull the APAC market down for a while
02:28because after China, if there was something that the world was looking forward to in terms of a transitional corridor
02:38for supply of goods to the U.S. and from the U.S. to APAC, then that was India.
02:43But with 25% tariff, this is not going to go a long way.
02:47But I also want to give a parallel perspective to this and this is to check our export baskets to the U.S.
02:55If we look at our export baskets to the U.S., then people pharmaceutical aside,
03:00we are not much in terms of exporting and that could save up from some kind of implications that are about to come.
03:08But if Donald Trump goes ahead and puts some kind of tariff on pharmaceuticals,
03:13then that will be something to look forward to because that will put us in a major trade deficit
03:19going to the fact that our pharma exports are maximum to the U.S.
03:23That's right. I'm going to talk to you about that and what's the kind of impact that's going to have on products
03:27that is being bought and sold.
Comments

Recommended